CAS 129453-61-8

General Information

Fulvestrant is used in the treatment of hormone-sensitive advanced breast cancer in postmenopausal women.

At Teva api, we offer a highly-pure Fulvestrant API. Our experience in producing high-potency products is vast and own 8-step back-integrated process in-house, providing greater control over the supply chain. This gives us a truly secured supply, as well as both high capacity and worldwide coverage for our customers, no matter their level of demand.


About the API

Systematic name 7α-[9-[(4,4,5,5,5-Pentafluoropentyl)-sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol
Trade name(s) Faslodex
Molecular Formula C32H47F5O3S
Therapeutic category Oncology
Available formulations Injectables Injectables Long-Acting
Regulations Canada DMF Flag Canada DMF CEP Flag CEP EU DMF Flag EU DMF Other Flag Other US DMF Flag US DMF